Medicines Updates and Statements Filter Options Archive DateYear20262025202420232022202120202019201820172016201520142013201220112010200920082007MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember View 12 View 12View 24View 48 Keywords All Keywords Covid-19FinanceInvestmentsLeadershipMedicinesPartnershipsResearchResponsibilityVaccines November 2019 11.15.2019 Pfizer Announces CHMP Opinion for XELJANZ® (tofacitinib) in the European Union Related to Ongoing Review of the ProductMedicines• • • June 2018 06.04.2018 Hospira Issues A Voluntary Nationwide Recall For Two Lots of Naloxone Hydrochloride Injection, USP, in the Carpuject™ Syringe System Due To The Potential Presence of Particulate Matter.Medicines• • • May 2018 05.09.2018 Important Notice Regarding EpiPen auto-injector supplyMedicines• • • March 2018 03.05.2018 Hospira Issues A Voluntary Nationwide Recall For Hydromorphone HCL Injection, USP CII Due To The Potential For Empty Or Cracked Glass VialsMedicines• • • February 2018 02.23.2018 Hospira Issues A Voluntary Nationwide Recall For Labetalol Hydrochloride Injection, USP, Due To The Potential Of Cracked Glass At The Rim Surface Of The VialsMedicines• • • Page 1 Page 2 Page 3 Page 4 Current page 5
